Endotoxemia: Clinical Trials

52 trials for Endotoxemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

41 completed, 6 unknown, 2 active not recruiting, 2 recruiting. 52 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable52Completed 41, Unknown 6, Active not recruiting 2, Recruiting 2, Not yet recruiting 1

Follow Endotoxemia: new trials by email Literature Review of Endotoxemia trials Research Report on Endotoxemia

Trials (filtered) newest first · largest first

All 52 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hemoadsorpion in Patients With Septic Shock: Efficacy and Safety Evaluation
Efferon LPS, Toramyxin PMX 20R, Jafron HA 330 - Septic Shock
Not applicableNot yet recruitingMoscow Multidisciplinary Clinical Center "Kommunarka"762026-06-252026-07-02
Short-Chain Fatty Acids in Lypopolysaccharide-Induced Inflammation and Executive Function
Short-Chain Fatty Acid Colon-Delivery Capsules, Placebo capsules, Lipopolysaccharide (LPS) - Endotoxemia, Inflammation
Not applicableRecruitingUniversitaire Ziekenhuizen KU Leuven562025-10-242026-07-20
Polyphenol Metabolism and Personalized Nutrition in Menopause (PolyPause).
Capsules containing plant extracts, including resveratrol, ellagic acid and isoflavones, Consumption of placebo - Menopause Related Conditions, Cardiovascular Risk
Not applicableActive not recruitingNational Research Council, Spain902024-01-152025-09-19
Different Dietary Patterns
Dietary intervention - Diet, Healthy, Endotoxemia
Not applicableUnknownUniversity of Vienna162023-10-202025-04-15
Dietary Intervention to Reduce Metabolic Endotoxemia
AIA-D, CONV-D - Endotoxemia, Intestinal Microbiota
Not applicableCompletedCentro de Investigación en Alimentación y Desarrollo A.C.722023-04-142024-02-07
Assessing Gut Microbiota Mediated Health Outcomes of Whole Wheat and Its Major Bioactive Components
Whole Wheat Bread, White Bread (control) - PreDiabetes, Dysbiosis
Not applicableActive not recruitingOhio State University652022-01-272025-11-20
Efficacy and Safety of Hemoperfusion With Polymyxin B in Septic Shock Associated With Severe Endotoxemia in Cardiac Surgery Patients (РМХ vs SS)
hemoperfusion with polymyxin B - Multiple Organ Dysfunction With Severe Endotoxemia
Not applicableRecruitingPetrovsky National Research Centre of Surgery202021-11-012024-11-25
The Effect of Probiotics on Systemic Inflammation and Metabolic Endotoxemia in Patients Undergoing Bariatric Surgery
probiotic supplementation, placebo - Bariatric Surgery Candidate, Dysbiosis
Not applicableUnknownMedical University of Gdansk802021-08-022022-06-07
Effects of Non-calorie Sweeteners, Mono- and Disaccharides on Intestinal Barrier Function
Dietary intervention 1, Dietary Intervention 2, Dietary Intervention 3 - Dietary Habits, Endotoxemia
Not applicableCompletedUniversity of Vienna182021-03-012023-11-01
Demonstration of the Prebiotic-like Effects of Camu-camu Consumption Against Obesity-related Disorders in Humans
Camu camu, Placebo - Overweight, Microtia
Not applicableCompletedLaval University352020-10-312022-10-04
Synergistic Innovative Functional Food Concepts to Neutralize Inflammation for Cardiometabolic Risk Prevention
bioactive components fortified food products intake (biscuits and cookies), control food products intake (biscuits and cookies) - Cardiometabolic Risk, Abdominal Obesity
Not applicableCompletedHospices Civils de Lyon622020-01-212025-09-25
Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study
Toraymyxin PMX 20R Extracorporeal Hemoperfusion Cartridge - Septic Shock, Endotoxemia
Not applicableCompletedSpectral Diagnostics (US) Inc.1572020-01-092026-10-13
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
Maple syrup, Placebo - Overweight, Microbiota
Not applicableCompletedLaval University472019-09-032024-04-15
Gut-level Antiinflammatory Activities of Green Tea in Metabolic Syndrome
Green Tea Extract, Placebo - Dysbiosis, Endotoxemia
Not applicableCompletedOhio State University462019-07-012025-12-19
Anabolic Potential of 3-hydroxybutyrate (3-OHB) and Whey Protein in a Human Catabolic Inflammatory Disease Model
Whey, 3-OHB + Whey - Endotoxemia, Muscle Loss
Not applicableCompletedUniversity of Aarhus82019-06-172020-06-11
Echocardiographic Changes After 3-hydroxy Butyrate+Whey Intake
Whey, 3-OHB + Whey - Cardiac Output, Endotoxemia
Not applicableCompletedUniversity of Aarhus82019-06-172020-06-11
Gastro-intestinal and Hormonal Responses to Systemic Inflammatory Disease
Whey, 3-OHB/whey - Motility Disorder, Catabolic State
Not applicableCompletedUniversity of Aarhus82019-06-172020-06-11
Determining the Fingerprint of Endotoxin Tolerance
Endotoxin (E. coli O:113, Reference Endotoxin) - Endotoxemia, Sepsis
Not applicableCompletedRadboud University Medical Center1102019-05-272025-02-07
Foodprint 1.0: Physiological Acute Responses After Consumption of Confectionary Products
control snack, control cream, cream version 1 - Glucose, High Blood, Inflammatory Response
Not applicableCompletedUniversity of Parma132019-03-222021-04-27
Effect of Cranberry and Agaves Extract on Microbiota and Intestinal Health
Cranberry, Agaves, Placebo - Endotoxemia, Metabolic Syndrome
Not applicableCompletedLaval University1222018-11-052023-03-21

Showing 20 of 52. Sign in to see all of them.

Narrower conditions

Inflammation (17)  ·  Sepsis (9)  ·  Insulin Resistance (6)  ·  Metabolic Syndrome (5)  ·  Obesity (5)  ·  Overweight (4)  ·  Diabetes Mellitus, Type 2 (3)  ·  Dysbiosis (3)  ·  Feeding Behavior (3)  ·  Shock, Septic (3)  ·  Non-alcoholic Fatty Liver Disease (2)  ·  Alcohol Drinking (1)  ·  Altitude Sickness (1)  ·  Anemia (1)

Broader conditions

Bacteremia (52)  ·  Infections (52)  ·  Pathologic Processes (52)  ·  Pathological Conditions, Signs and Symptoms (52)  ·  Systemic Inflammatory Response Syndrome (52)  ·  Toxemia (52)  ·  Sepsis (43)  ·  Inflammation (35)  ·  Nutritional and Metabolic Diseases (17)  ·  Signs and Symptoms (13)  ·  Body Weight (10)  ·  Metabolic Diseases (10)  ·  Nutrition Disorders (10)  ·  Overnutrition (10)  ·  Glucose Metabolism Disorders (9)

Interventions

Endotoxins (6)  ·  Lipopolysaccharides (5)  ·  Whey (4)  ·  endotoxin, Escherichia coli (4)  ·  Diet Therapy (3)  ·  Aspirin (2)  ·  Tea (2)  ·  3-(2,4-dimethoxybenzylidene)anabaseine (1)  ·  Atazanavir Sulfate (1)  ·  Caseins (1)  ·  Ciprofloxacin (1)  ·  Clopidogrel (1)  ·  Complement C1 Inhibitor Protein (1)  ·  Deferasirox (1)  ·  Ellagic Acid (1)

Sponsors

Radboud University Medical Center (12)  ·  University of Aarhus (5)  ·  Copenhagen University Hospital, Rigshospitalet (4)  ·  Laval University (4)  ·  Ohio State University (4)  ·  University of Vienna (3)  ·  Hospices Civils de Lyon (2)  ·  Spectral Diagnostics (US) Inc. (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Centre de Recherche en Nutrition Humaine Rhone-Alpe (1)  ·  Centro de Investigación en Alimentación y Desarrollo A.C. (1)  ·  Green Beat (1)  ·  Herlev Hospital (1)  ·  Iowa State University (1)  ·  Medical University of Gdansk (1)

Countries

Netherlands (13)  ·  Denmark (10)  ·  United States (7)  ·  Canada (5)  ·  Austria (4)  ·  France (4)  ·  Russia (2)  ·  Belgium (1)  ·  Italy (1)  ·  Mexico (1)  ·  Poland (1)  ·  Spain (1)

Top investigators

Niels Moeller, Professor (5)  ·  Peter Pickkers, MD, PhD (4)  ·  Anne Sofie Andreasen, MD (3)  ·  Richard Bruno, PhD, RD (3)  ·  Bente K Pedersen, MD, DMSc (1)  ·  Boushra Dalile, PhD (1)  ·  Denis Protsenko, MD, PHD (1)  ·  Dorthe H Olsen, DM (1)  ·  Dorthe H Olsen, MD (1)  ·  Emmanuel Huet, MD (1)  ·  James H Hollis, PhD (1)  ·  Jelle Zwaag, MSc (1)  ·  Johannes Van der Hoeven, PhD, MD (1)

Results publications

PMID 40517600, PMID 21931634, PMID 22162470, PMID 22822024, PMID 22992437, PMID 23235199, PMID 24684464, PMID 24916483, PMID 25916910, PMID 26151336, PMID 27307305, PMID 27816052, PMID 28545546, PMID 30260393, PMID 30304428, PMID 30418539, PMID 30470853, PMID 33693737, PMID 34566840, PMID 34837121, PMID 35213875, PMID 37261364, PMID 37892479, PMID 38214917, PMID 38430822, PMID 39163971, PMID 39168095, PMID 39710576, PMID 40670486, PMID 41068905, PMID 41837287, PMID 41887242, PMID 42729417

NIH funding

2014 (2), 2016 (1)